PL436784A1 - Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy - Google Patents

Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy

Info

Publication number
PL436784A1
PL436784A1 PL436784A PL43678421A PL436784A1 PL 436784 A1 PL436784 A1 PL 436784A1 PL 436784 A PL436784 A PL 436784A PL 43678421 A PL43678421 A PL 43678421A PL 436784 A1 PL436784 A1 PL 436784A1
Authority
PL
Poland
Prior art keywords
polymerase
neqssb
pwo
primers
recombinant plasmid
Prior art date
Application number
PL436784A
Other languages
English (en)
Other versions
PL241698B1 (pl
Inventor
Marta SKWARECKA
Kasjan SZEMIAKO
Marcin Olszewski
Sabina ŻOŁĘDOWSKA
Dawid NIDZWORSKI
Original Assignee
Instytut Biotechnologii I Medycyny Molekularnej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii I Medycyny Molekularnej filed Critical Instytut Biotechnologii I Medycyny Molekularnej
Priority to PL436784A priority Critical patent/PL241698B1/pl
Priority to EP22153626.1A priority patent/EP4036237A1/en
Publication of PL436784A1 publication Critical patent/PL436784A1/pl
Publication of PL241698B1 publication Critical patent/PL241698B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Przedmiotem wynalazku jest polimeraza Pwo-NeqSSB oraz sposób jej klonowania. Ponadto przedmiotem wynalazku jest wyizolowany plazmid rekombinantowy, startery oraz zastosowanie polimerazy do powielania specyficznych sekwencji wirusa SARS CoV-2.
PL436784A 2021-01-27 2021-01-27 Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy PL241698B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL436784A PL241698B1 (pl) 2021-01-27 2021-01-27 Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
EP22153626.1A EP4036237A1 (en) 2021-01-27 2022-01-27 Pwo-neqssb polymerase, method of its preparation, recombinant plasmid, primers and the use of polymerase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL436784A PL241698B1 (pl) 2021-01-27 2021-01-27 Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy

Publications (2)

Publication Number Publication Date
PL436784A1 true PL436784A1 (pl) 2022-08-01
PL241698B1 PL241698B1 (pl) 2022-11-21

Family

ID=80445772

Family Applications (1)

Application Number Title Priority Date Filing Date
PL436784A PL241698B1 (pl) 2021-01-27 2021-01-27 Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy

Country Status (2)

Country Link
EP (1) EP4036237A1 (pl)
PL (1) PL241698B1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
PL426093A1 (pl) * 2018-06-27 2020-01-02 Instytut Biotechnologii I Medycyny Molekularnej Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie
CN111549177A (zh) * 2020-04-27 2020-08-18 广州再生医学与健康广东省实验室 用于检测SARS-CoV-2的gRNA及试剂盒
PL241065B1 (pl) * 2020-06-26 2022-08-01 Geneme Spolka Z Ograniczona Odpowiedzialnoscia Zastosowanie fuzyjnej polimerazy DNA Bst-Nec do izotermalnego powielania specyficznych sekwencji wirusa SARS CoV-2

Also Published As

Publication number Publication date
PL241698B1 (pl) 2022-11-21
EP4036237A1 (en) 2022-08-03

Similar Documents

Publication Publication Date Title
MX2020004578A (es) Composiciones de casz y metodos de uso.
AR114551A1 (es) COMPOSICIONES DE AGENTES DE ARNhd CONTRA EL VIRUS DE HEPATITIS B (HBV) Y MÉTODOS PARA SU USO
MX2022016066A (es) Nuevo inhibidor de proteina-cinasa-cinasa activada por mitogeno (mek) para el tratamiento de infecciones virales y bacterianas.
EP4242223A3 (en) Modified mrna vaccines encoding herpes simplex virus glycoproteins and uses thereof
EA202090090A1 (ru) Включение неприродных нуклеотидов и способы с ними
GT201600201A (es) Derivados de nucleósido 4'-sustituidos como inihbidores de la transcriptasa reversa de vih
MX2018004916A (es) Vacuna contra el virus de la influenza de amplio espectro.
GEAP202115353A (en) Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
PH12020551637A1 (en) Additives for protein formulations to improve thermal stability
EP4647079A3 (en) Hepatitis b virus (hbv) irna compositions and methods of use thereof
CA2998646C (en) 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
BR112019024813A2 (pt) adenovírus recombinantes portando transgenes
PH12017500449A1 (en) Methods and compositions for inducing protective immunity against human immunodeficiency virus infection
MX2022011394A (es) Composiciones y metodos para la induccion de una respuesta inmune.
PH12021552870A1 (en) Compositions and methods for treating hepatitis b virus (hbv) infection
MX2020009556A (es) Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla.
JP2019509717A5 (pl)
WO2008151633A3 (en) Vectors for vaccines against lentivirus infections
PH12015502666B1 (en) Dengue virus vaccine compositions and methods of use thereof
PL437909A1 (pl) Polimeraza Taq-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
PL436784A1 (pl) Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
MY192543A (en) Dengue virus vaccine compositions and methods of use thereof
EP4282960A3 (en) Modified lipase and use thereof
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
WO2021019235A3 (en) Hantavirus antigenic composition